<DOC>
	<DOC>NCT00933179</DOC>
	<brief_summary>The aim of the present study is to investigate the effects of the transdermal patch on the parameters of hemostasis (blood clotting), lipid (fat), and carbohydrate (sugars) metabolism in healthy women who require contraception.</brief_summary>
	<brief_title>FC Patch Low: Metabolism Study</brief_title>
	<detailed_description />
	<mesh_term>Levonorgestrel</mesh_term>
	<mesh_term>Ethinyl estradiol, levonorgestrel drug combination</mesh_term>
	<mesh_term>Gestodene</mesh_term>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<criteria>Healthy woman requesting contraception Normal cervical smear not requiring further followup History of regular cyclic menstrual periods Willingness to use nonhormonal contraception during the two washout cycles both before the start of treatment and between the two treatment periods Pregnancy or lactation Obesity (Body Mass Index [BMI] &gt; 30.0 kg/m2) Any diseases or conditions that can compromise the function of the body systems Any diseases or conditions that might interfere with the conduct of the study or the interpretation of the results Any disease or condition that may worsen under hormonal treatment Undiagnosed abnormal genital bleeding Any medication that could result in excessive accumulation, impaired metabolism, or altered excretion of the study drug or interfere with the conduct of the study or the interpretation of the results</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Prevention of pregnancy</keyword>
</DOC>